These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18929839)
1. Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Jang JH; Kang KJ; Kim YH; Kang YN; Lee IS Transplant Proc; 2008 Oct; 40(8):2700-3. PubMed ID: 18929839 [TBL] [Abstract][Full Text] [Related]
2. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942 [TBL] [Abstract][Full Text] [Related]
3. Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Wallace MC; Hamesch K; Lunova M; Kim Y; Weiskirchen R; Strnad P; Friedman SL Lab Anim; 2015 Apr; 49(1 Suppl):21-9. PubMed ID: 25835735 [TBL] [Abstract][Full Text] [Related]
4. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1. Kornek M; Raskopf E; Guetgemann I; Ocker M; Gerceker S; Gonzalez-Carmona MA; Rabe C; Sauerbruch T; Schmitz V J Hepatol; 2006 Sep; 45(3):370-6. PubMed ID: 16780996 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992 [TBL] [Abstract][Full Text] [Related]
6. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats. Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861 [TBL] [Abstract][Full Text] [Related]
7. [An experimental model of hepatic fibrosis induced by alcohol and CCl4: can the lipopolysaccharide prevent liver injury induced by alcohol and CCl4?]. Chae HB; Jang LC; Park SM; Son BR; Sung R; Choi JW Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):173-8. PubMed ID: 12499803 [TBL] [Abstract][Full Text] [Related]
8. Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl4, and TAA. Park HJ; Kim HG; Wang JH; Choi MK; Han JM; Lee JS; Son CG Drug Chem Toxicol; 2016; 39(1):111-8. PubMed ID: 26045230 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. Natarajan SK; Thomas S; Ramamoorthy P; Basivireddy J; Pulimood AB; Ramachandran A; Balasubramanian KA J Gastroenterol Hepatol; 2006 Jun; 21(6):947-57. PubMed ID: 16724977 [TBL] [Abstract][Full Text] [Related]
10. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Constantinou MA; Theocharis SE; Mikros E Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614 [TBL] [Abstract][Full Text] [Related]
11. Experimental thioacetamide-induced cirrhosis of the liver. Muñoz Torres E; Paz Bouza JI; López Bravo A; Abad Hernández MM; Carrascal Marino E Histol Histopathol; 1991 Jan; 6(1):95-100. PubMed ID: 1806061 [TBL] [Abstract][Full Text] [Related]
12. Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in rats. Kim SK; Seo JM; Chae YR; Jung YS; Park JH; Kim YC Chem Biol Interact; 2009 Feb; 177(3):204-11. PubMed ID: 18930038 [TBL] [Abstract][Full Text] [Related]
13. A useful model to audit liver resolution from cirrhosis in rats using functional proteomics. Liu EH; Chen MF; Yeh TS; Ho YP; Wu RC; Chen TC; Jan YY; Pan TL J Surg Res; 2007 Apr; 138(2):214-23. PubMed ID: 17292413 [TBL] [Abstract][Full Text] [Related]
14. Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS). Dranoff JA; Kruglov EA; Abreu-Lanfranco O; Nguyen T; Arora G; Jain D In Vivo; 2007; 21(6):957-65. PubMed ID: 18210741 [TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatic fibrosis in nonobese diabetic mice: a critical role for interferon-gamma. Mukai T; Nagaki M; Imose M; Kimura K; Satake S; Takai S; Moriwaki H Liver Int; 2006 Oct; 26(8):1006-14. PubMed ID: 16953842 [TBL] [Abstract][Full Text] [Related]
16. Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Moal F; Chappard D; Wang J; Vuillemin E; Michalak-Provost S; Rousselet MC; Oberti F; Calès P Hepatology; 2002 Oct; 36(4 Pt 1):840-9. PubMed ID: 12297831 [TBL] [Abstract][Full Text] [Related]
17. [Effects of cianidanol (KB-53) on liver cirrhosis induced by CCl4 in rats: a pathological investigation]. Takebe H; Sato I; Tajima S; Ikeda Y; Ito K; Nose T Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):585-91. PubMed ID: 6618347 [TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. Zou YH; Yang Y; Li J; Wu Q; Li WP; Lu JT; Roberts MS J Ethnopharmacol; 2008 Dec; 120(3):452-7. PubMed ID: 18951966 [TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482 [TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosis. George J Clin Biochem; 2006 Oct; 39(10):984-91. PubMed ID: 16959231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]